Panel: Understanding the Global Trends Reshaping Expanded Access in 2027

8:30 am - Wednesday 24th March 2027

  • Examining how Expanded Access is evolving from a reactive access mechanism to a strategic function embedded within launch planning, post-trial access and evidence generation
  • Assessing the growing impact of post-trial access, global pricing pressures and reimbursement considerations on program design
  • Understanding how geopolitical, regulatory and market dynamics are influencing access strategies across different regions
  • Identifying the biggest opportunities, risks and priorities shaping Expanded Access over the next 12-24 months

Speakers:

Head, North America Medical Governance
Merck
Vice President, International Business
Sarepta Therapeutics